AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17197592
Drug: Intracervical saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracervical saline injection
Trial: 9635947
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid 75 mg/day
Trial: 8162627
Drug: Colestipol 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colestipol 10 g and Simvastatin 10 mg/day (CS)
Trial: 8162627
Drug: Colestipol 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colestipol 10 g and Bezafibrate 400 mg/day (CB)
Trial: 2735338
Drug: Sucralfate tablets
RxNorm normalized name: Sucralfate Tablets
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucralfate tablets
Trial: 4985836
Drug: 5 ml.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml. of packed group O R(2)R(2) cells, administered by intravenous injection
Trial: 4985836
Drug: 0.5 ml.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 ml. of packed group O R(2)R(2) cells, administered by intravenous injection
Trial: 4985836
Drug: Initial antibodies
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial antibodies comprised 7S gammaG immunoglobulins with a minor 19S gammaM component in about half the cases
Trial: 22420399
Drug: DynaClose topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DynaClose topical tissue expansion device
Trial: 18753738
Drug: Acetylcysteine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetylcysteine (600 mg orally t.i.d.)
Trial: 17994436
Drug: Azithromycin, single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin, single 1 gram dose
Trial: 17994436
Drug: Topical tetracycline,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical tetracycline, twice per day for six weeks
Trial: 15487810
Drug: ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ezetimibe 10 mg once daily
Trial: 15487810
Drug: gemfibrozil 600
RxNorm normalized name: gemfibrozil 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gemfibrozil 600 mg every 12 hours
Trial: 15487810
Drug: ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ezetimibe 10 mg once daily plus gemfibrozil 600 mg every 12 hours
Trial: 11571454
Drug: Oral ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ganciclovir 3x1 g/day for 14 days
Trial: 11571454
Drug: No preemptive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No preemptive treatment (Control group)
Trial: 11571454
Drug: Intravenous ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ganciclovir 2x5 mg/kg body weight for 14 days (for those who developed CMV disease)
Trial: 9804594
Drug: Cocaine administration
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine administration (0.4 mg/kg)
Trial: 7822675
Drug: Daily Disposable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily Disposable Wear (DDW)
Trial: 7822675
Drug: Conventional Daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Daily Wear (CDW)
Trial: 26865198
Drug: Good adherence
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Good adherence (cumulative medication adherence, ≥80%)
Trial: 26865198
Drug: Poor adherence
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Poor adherence (cumulative medication adherence, <50%)
Trial: 26865198
Drug: Intermediate adherence
RxNorm normalized name: Prevotella intermedia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermediate adherence (cumulative medication adherence, 50%-80%)
Trial: 17218552
Drug: Inhaled tiotropium
RxNorm normalized name: tiotropium Inhalation Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled tiotropium
Trial: 9554820
Drug: s.c. rHu‐EPO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: s.c. rHu‐EPO (2000 U/twice weekly)
Trial: 9554820
Drug: s.c. rHu‐EPO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: s.c. rHu‐EPO (3000 U twice weekly after 6 weeks if Hb increase was below 1 g%)
Trial: 9554820
Drug: s.c. rHu‐EPO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: s.c. rHu‐EPO therapy
Trial: 8060471
Drug: Cyclosporin and
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin and prednisolone (double therapy)
Trial: 8060471
Drug: Cyclosporin, prednisolone,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin, prednisolone, and azathioprine (triple therapy)
Trial: 28633774
Drug: Electric shockwave
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Electric shockwave therapy
Trial: 21438131
Drug: Piperacillin/tazobactam (PIP/TAZO)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin/tazobactam (PIP/TAZO) 125 mg/kg every 8 hr
Trial: 21438131
Drug: Cefozopran (CZOP)
RxNorm normalized name: cefozopran
DrugBank: Cefozopran (DB13667)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefozopran (CZOP) 25 mg/kg every 6 hr
Trial: 19569068
Drug: Facilitated PCI
RxNorm normalized name: PCI-27483
DrugBank: PCI-27483 (DB13000)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Facilitated PCI (high-dose tirofiban)
Trial: 11071026
Drug: Latanoprost, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Latanoprost, 50 microg/ml once daily
Trial: 11071026
Drug: Timolol 5
RxNorm normalized name: timolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol 5 mg/ml plus dorzolamide, 20 mg/ml twice daily
Trial: 9071196
Drug: Early reperfusion
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early reperfusion therapy (within six hours)
Trial: 9071196
Drug: Late reperfusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late reperfusion therapy (after six hours)
Trial: 2425315
Drug: Epidural hydromorphone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural hydromorphone (1.0 mg in 10 mL preservative-free saline)
Trial: 2425315
Drug: Epidural bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural bupivacaine (10 mL of 0.25%)
Trial: 31525795
Drug: Cocktail of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocktail of medications (CO)
Trial: 27511740
Drug: Individual standardized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual standardized reminiscence therapy performed by trained nursing home volunteers
Trial: 18835314
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A supplementation (15 mg retinol equivalent) alongside the pentavalent vaccine
Trial: 18835314
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A supplementation with pentavalent vaccine
Trial: 16681880
Drug: Aspirin 80
RxNorm normalized name: aspirin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 80 mg/d
Trial: 16681880
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg/d (HNPCC)
Trial: 9369038
Drug: Conventional drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional drug treatment alone
Trial: 3514233
Drug: Cisapride (slow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride (slow i.v. injection)
Trial: 3514233
Drug: Placebo (slow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (slow i.v. injection)
Trial: 8164028
Drug: Dolasetron mesylate
RxNorm normalized name: Dolasetron Mesylate
DrugBank: Dolasetron (DB00757)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dolasetron mesylate (1.8, 2.4, 3.0, and 5.0 mg/kg) administered intravenously over 20 minutes, starting 30 minutes before chemotherapy.
Trial: 8164028
Drug: Dolasetron mesylate
RxNorm normalized name: Dolasetron Mesylate
DrugBank: Dolasetron (DB00757)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dolasetron mesylate (doses > 2.4 mg/kg)
Trial: 1920009
Drug: Routine maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine maintenance therapy (RMT)
Trial: 582685
Drug: L-tryptophane plus
RxNorm normalized name: L-TRYPTOPHAN
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-tryptophane plus oxprenolol
Trial: 20478383
Drug: Quercetin 500
RxNorm normalized name: quercetin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quercetin 500 mg/day for 12 weeks
Trial: 31519283
Drug: Starch placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Starch placebo 500 mg/day for 12 weeks
Trial: 28095099
Drug: Exercise-nutritional supplement
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise-nutritional supplement program (ENP)
Trial: 17917321
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg plus Hydrochlorothiazide 12.5 mg
Trial: 17917321
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg plus Hydrochlorothiazide 6.25 mg
Trial: 17917321
Drug: Losartan 25
RxNorm normalized name: LOSARTAN 25MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 25 mg plus Hydrochlorothiazide 6.25 mg
Trial: 15536109
Drug: Carvedilol (6.25-25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (6.25-25 mg, twice daily)
Trial: 15536109
Drug: Metoprolol tartrate
RxNorm normalized name: Metoprolol Tartrate
DrugBank: Metoprolol (DB00264)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoprolol tartrate (50-200 mg, twice daily)
Trial: 21166828
Drug: Emdogain Gel
RxNorm normalized name: Memogain
DrugBank: Benzgalantamine (DB19353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emdogain Gel (Biora AB, Malmö, Sweden)
Trial: 7934491
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg cA2
Trial: 7934491
Drug: 10 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/kg cA2
Trial: 2904392
Drug: sulphasalazine 2
RxNorm normalized name: Sulfasalazine
DrugBank: Sulfasalazine (DB00795)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sulphasalazine 2 g/day
Trial: 21729166
Drug: 311 nm
RxNorm normalized name: NM-004
DrugBank: NM-004 (DB18066)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 311 nm UVB therapy
Trial: 10903487
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 250 microg twice daily
Trial: 9018514
Drug: Topical upper
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical upper airway anesthesia with 0.2% tetracaine
Trial: 29864430
Drug: Oral glucosamine
RxNorm normalized name: glucosamine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucosamine hydrochloride (1.44 g/day) combined with hyaluronate sodium injections
Trial: 29864430
Drug: Oral placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral placebo combined with hyaluronate sodium injections
Trial: 23763270
Drug: Topical nicotinamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nicotinamide (NCT) 4% cream
Trial: 19828470
Drug: Mepolizumab (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepolizumab (750 mg, n = 5)
Trial: 19828470
Drug: Mepolizumab (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepolizumab (1500 mg, n = 5)
Trial: 12143913
Drug: Paroxetine controlled-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine controlled-release (CR) 25-62.5 mg/day
Trial: 12143913
Drug: Paroxetine immediate-release
RxNorm normalized name: paroxetine Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine immediate-release (IR) 20-50 mg/day
Trial: 9868616
Drug: Silver preparations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silver preparations in burns
Trial: 1832454
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg naproxen b.i.d. for 3 months
Trial: 30716790
Drug: Early Calsurf
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early Calsurf administration (n=154)
Trial: 30716790
Drug: Rescue Calsurf
RxNorm normalized name: ALLERGENIC EXTRACT, MEADOW FESCUE POLLEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rescue Calsurf administration (n=151)
Trial: 27679519
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with losartan
Trial: 6160345
Drug: Low-dose furosemide
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose furosemide (40 mg/day)
Trial: 6160345
Drug: Normal controls
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal controls (no therapy)
Trial: 31116151
Drug: Doxazosin mesylate
RxNorm normalized name: Doxazosin Mesylate
DrugBank: Doxazosin (DB00590)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxazosin mesylate GITS (4 mg/day)
Trial: 31116151
Drug: Nifedipine GITS
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine GITS (30 mg/day)
Trial: 25928214
Drug: DrotAA +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DrotAA + steroids
Trial: 25928214
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + steroids
Trial: 17207038
Drug: Hypothetical preventer
RxNorm normalized name: Preventeza
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Hypothetical preventer medication
Trial: 17207038
Drug: Current inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current inhaled corticosteroid medication
Trial: 17207038
Drug: No asthma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No asthma medication
Trial: 15146933
Drug: Epinastine hydrochloride
RxNorm normalized name: Epinastine Hydrochloride
DrugBank: Epinastine (DB00751)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epinastine hydrochloride (20 mg/day, once daily)
Trial: 28042082
Drug: Chard gel
RxNorm normalized name: SWISS CHARD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chard gel (GEL)
Trial: 24053706
Drug: SLIT (sublingual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SLIT (sublingual immunotherapy)
Trial: 24053706
Drug: SCIT (subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCIT (subcutaneous immunotherapy)
Trial: 21703676
Drug: Outpatient treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient treatment with subcutaneous enoxaparin (≥5 days) followed by oral anticoagulation (≥90 days)
Trial: 21703676
Drug: Inpatient treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inpatient treatment with subcutaneous enoxaparin (≥5 days) followed by oral anticoagulation (≥90 days)
Trial: 19231298
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy (24 sessions over 3 months)
Trial: 15142202
Drug: Lansoprazole 60
RxNorm normalized name: dexlansoprazole 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 60 mg am and 30 mg pm for 7 days
Trial: 11114574
Drug: L-carnitine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine (500 mg/day) for 3 months
Trial: 9496487
Drug: Standardized oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized oral desensitization program
Trial: 7766945
Drug: Phenylalanine-restricted diet,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylalanine-restricted diet, maintaining maternal blood phenylalanine levels between 120 and 360 mumol/l before conception and during pregnancy.
Trial: 31537420
Drug: suxamethonium 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: suxamethonium 1 mg/kg
Trial: 11521932
Drug: Low-energy shock-wave
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-energy shock-wave therapy (ESWT), 6,000 impulses (energy flux density, 0.11 mJ/mm2) in three sessions after local anaesthesia
Trial: 3946248
Drug: Metoprolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (100 to 300 mg/day)
Trial: 3946248
Drug: Pindolol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (5 to 15 mg/day)
Trial: 24452085
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with graduated middle stretch compression bandage and low dose unfractionated heparin (LDUH) injections
Trial: 20044067
Drug: Electronic prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electronic prescription for calcium carbonate with vitamin D supplement
Trial: 19080566
Drug: AutoCPAP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AutoCPAP treatment for 1 month
Trial: 19080566
Drug: ASV treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASV treatment for 1 week
Trial: 16719171
Drug: Ifosphamide (IF)
RxNorm normalized name: Ifosfamide
DrugBank: Ifosfamide (DB01181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ifosphamide (IF) treatment in doses from 1.5 g/m2 to 3 g/m2 for 3 to 5 days.
Trial: 12869359
Drug: Oxygen (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen (3 L/minute)
Trial: 12869359
Drug: Air (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air (3 L/minute)
Trial: 10868714
Drug: Pressurized metered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pressurized metered dose inhaler (pMDI)
Trial: 2067212
Drug: Monoclonal antibody
RxNorm normalized name: Monoclonal antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monoclonal antibody (mAb) against human IL-6
Trial: 6437128
Drug: Danazol 400
RxNorm normalized name: Danazol
DrugBank: Danazol (DB01406)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Danazol 400 mg
Trial: 6437128
Drug: Danazol 600
RxNorm normalized name: Danazol
DrugBank: Danazol (DB01406)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Danazol 600 mg
Trial: 6437128
Drug: Danazol 800
RxNorm normalized name: Danazol
DrugBank: Danazol (DB01406)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Danazol 800 mg
Trial: 30040706
Drug: Active ultrasound
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active ultrasound therapy in addition to hotpack, TENS, and exercise
Trial: 20630656
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of morphine with an NMDA‐receptor antagonist
Trial: 12518850
Drug: Sulfadoxine‐pyrimethamine (SP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfadoxine‐pyrimethamine (SP) treatment
Trial: 9706827
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy administered in prehospital setting (Gr.1)
Trial: 9706827
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy administered in hospital setting (Gr.2)
Trial: 2653174
Drug: Clonidine (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.3 mg per os)
Trial: 9291
Drug: Chlorthalidone 100
RxNorm normalized name: chlorthalidone 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone 100 mg/day
Trial: 9291
Drug: Chlorthalidone 200
RxNorm normalized name: Chlorthalidone
DrugBank: Chlorthalidone (DB00310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone 200 mg/day
Trial: 29798418
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human IL‐11 treatment
Trial: 23118268
Drug: 10-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV)
Trial: 23118268
Drug: 7-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent pneumococcal conjugate vaccine (7vCRM)
Trial: 7936516
Drug: 2-mg intravaginal
RxNorm normalized name: taurolidine
DrugBank: Taurolidine (DB12473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-mg intravaginal prostaglandin E2 (PGE2) suppositories
Trial: 3585441
Drug: Adr 70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adr 70 mg/m2 IV day 1 and every 3 weeks
Trial: 3585441
Drug: Adr 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adr 20 mg/m2 IV day 1, 2, and 3, and 15 mg/m2 IV day 8 and weekly thereafter
Trial: 3585441
Drug: Adr 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adr 60 mg/m2 IV day 1 and DTIC 250 mg/m2 days 1 to 5, repeated every 3 weeks
Trial: 3585441
Drug: Adr weekly
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adr weekly